Tag Archive | "symbiomix"

Series A financing for $41 million for Symbiomix

Tags: ,

Symbiomix Therapeutics announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV). Read the full story